Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Merrimack Pharmaceuticals Initiates Enrollment In Phase 2 Study Of MM-121 In Combination With Erlotinib In Three Groups Of Patients With Lung Cancer

Merrimack Pharmaceuticals, Inc. announced that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib (Tarceva┬«), a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer (NSCLC)…

Go to Source

Leave a Reply

News

Weight loss drug may prevent and treat diabetes

A new clinical trial reports that a weight loss drug can reduce diabetes risk and increases the chances of remission among those who have the condition. Powered by WPeMatico

more >

Drug resistance: ‘Trojan horse’ compound kills bacteria from within

Researchers have found a way to ‘trick’ bacteria into eating a compound that is similar to iron and destroys the microbes from the inside. Powered by WPeMatico

more >

New cancer vaccine may tackle HER2-positive tumors

A new cancer vaccine shows promise for treating a range of more aggressive HER2-positive cancers in an early, phase I clinical trial. Powered by WPeMatico

more >

Using the body clock to make drugs more effective

A new database of circadian changes in genetic expression can help physicians time drugs so that they’re synched up to the patient’s body clock. Powered by WPeMatico

more >

MS: New drug proven to slow brain shrinkage

A randomized, placebo-controlled trial shows that a new drug can reduce the atrophy of the brain, which is a hallmark of multiple sclerosis. Powered by WPeMatico

more >

Opioid crisis breakthrough: Non-addictive painkiller found effective

Researchers have developed a compound that simultaneously stops the addictive action of opioids and relieves chronic pain as effectively as morphine. Powered by WPeMatico

more >